Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages.

Debon, R; Breilh, D; Boselli, E; Saux, M C; Duflo, F; Chassard, D; Allaouchiche, B

Debon, R; Breilh, D; Boselli, E; Saux, M C; Duflo, F; Chassard, D; Allaouchiche, B.

Affiliation

Debon R; Intensive Care Department, Hôtel-Dieu, Lyon, France.

J Chemother ; 14(2): 175-80, 2002 Apr.

Article in En | MEDLINE | ID: mdl-12017373

Subject(s)

Anti-Infective Agents/pharmacokinetics; Ciprofloxacin/pharmacokinetics; Pneumonia, Bacterial/metabolism; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents/administration & dosage; Biological Availability; Ciprofloxacin/administration & dosage; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ciprofloxacin / Pneumonia, Bacterial / Anti-Infective Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2002 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links